Background High-grade gliomas are the most common primary brain tumours.
Pseudoprogression describes the false appearance of radiation-induced progression on …

Magnetic resonance imaging–guided adaptive radiotherapy would make available the best
in anatomical and functional imaging during the course of radiation therapy. The possible …

After chemoradiotherapy for glioblastoma, pseudoprogression can occur and must be
distinguished from true progression to correctly manage glioblastoma treatment and follow …

The use of contrast enhancement within the brain on CT or MRI has been the gold standard
for diagnosis and therapeutic response assessment in malignant gliomas for decades. The …

With new therapeutic protocols, more patients treated for glioblastoma have experienced a
suspicious radiologic image of progression (pseudoprogression) during follow-up …

BACKGROUND AND PURPOSE: A limitation in postoperative monitoring of patients with
glioblastoma is the lack of objective measures to quantify residual and recurrent disease …

Purpose Molecular diagnostics including next generation gene sequencing are increasingly
used to determine options for individualized therapies in brain tumor patients. We aimed to …

RATIONALE AND OBJECTIVES: Quantitative measurement provides essential information
about disease progression and treatment response in patients with glioblastoma multiforme …

Background: Use of strongly hypofractionated radiation treatments in dogs with intracranial
neoplasia did not improve outcomes and yielded increased rates of toxicosis. Objectives: To …

Molecular markers define the diagnosis of glioblastoma in the new WHO classification of
2016, challenging neuro-oncology centers to provide timely treatment initiation. The aim of …